Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Rangering i aksjer #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Aksjekurs
$0.0036163
Sist synkronisert: 2023-10-30
Markedsverdi
$118.21K
Endring (1 dag)
0.39%
Endring (1 år)
0.00%
Land
CA
Handel Canntab Therapeutics Limited (PILL)

Kategori

P/B-forhold for Canntab Therapeutics Limited (PILL)
P/B-forhold per 2026 TTM: 0
Ifølge Canntab Therapeutics Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Canntab Therapeutics Limited fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter